Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease

The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up.

Detalles Bibliográficos
Autores principales: Orbak, Zerrin, Laloglu, Fuat, Akat, Hulya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737124/
https://www.ncbi.nlm.nih.gov/pubmed/33183365
http://dx.doi.org/10.1017/S1047951120004291
_version_ 1783622891606114304
author Orbak, Zerrin
Laloglu, Fuat
Akat, Hulya
author_facet Orbak, Zerrin
Laloglu, Fuat
Akat, Hulya
author_sort Orbak, Zerrin
collection PubMed
description The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up.
format Online
Article
Text
id pubmed-7737124
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-77371242020-12-15 Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease Orbak, Zerrin Laloglu, Fuat Akat, Hulya Cardiol Young Brief Report The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up. Cambridge University Press 2020-11-13 /pmc/articles/PMC7737124/ /pubmed/33183365 http://dx.doi.org/10.1017/S1047951120004291 Text en © Cambridge University Press 2020 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Orbak, Zerrin
Laloglu, Fuat
Akat, Hulya
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease
title Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease
title_full Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease
title_fullStr Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease
title_full_unstemmed Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease
title_short Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease
title_sort effectiveness of lopinavir/ritonavir on covid-19-related pneumonia in a child with covid-19-associated kawasaki disease
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737124/
https://www.ncbi.nlm.nih.gov/pubmed/33183365
http://dx.doi.org/10.1017/S1047951120004291
work_keys_str_mv AT orbakzerrin effectivenessoflopinavirritonavironcovid19relatedpneumoniainachildwithcovid19associatedkawasakidisease
AT laloglufuat effectivenessoflopinavirritonavironcovid19relatedpneumoniainachildwithcovid19associatedkawasakidisease
AT akathulya effectivenessoflopinavirritonavironcovid19relatedpneumoniainachildwithcovid19associatedkawasakidisease

Ejemplares similares